Navigation Links
AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
Date:1/25/2008

TUSTIN, Calif., Jan. 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc., is an international biopharma company that, together with Jade, engages in the development, manufacture and marketing of proprietary pharmaceutical, health care and diagnostic products. It today announced that more than 100 individual owners of existing health spa centers in China have signed strategic cooperation agreements with JJB, a Jade subsidiary.

The agreements allow JJB to re-brand the locations as JPGreen anti-aging & spa clinics. JJB is the exclusive supplier of its anti-aging product "Goodnak." The agreements follow a January meeting at the Beijing Diaoyutai State Guesthouse that attracted approximately 200 health spa center owners who want to cooperate with JJB in order to expand the JPGreen centers.

Frank Zhang, Managing Director of Jade, stated that "these new strategic cooperation agreements will allow JJB to increase the sales of the expanding family of Goodnak anti-aging injections, capsules, creams and spray products into the China market during 2008. Each new clinic location is anticipated to annually contribute $400,000 to $700,000 in gross sales per location."

Mr. Gary Dreher, CEO of AMDL noted that "these new regional Chinese strategic cooperation relationships are significant achievements and improves Jade's ability to grow its sales in 2008 and beyond."

About Jade Pharmaceutical: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice ('CGMP') st
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... --  Propeller Health , the FDA-cleared digital health solution ... Brad Towle as Senior Vice President, Business and ... company,s sales growth, customer acquisition and program expansion. ... past role in the development of accountable care organizations, ... time in the industry," said David Van Sickle ...
(Date:7/28/2014)... California (PRWEB) July 28, 2014 The ... 604.40 billion by 2020, according to a new study ... with the rising demand for effective vaccines and drugs ... with unmet medical needs is expected to drive market ... need to enhance agricultural productivity via the use of ...
(Date:7/28/2014)... July 28, 2014 Research and Markets ... Analysis Market 2014-2018" report to their offering. ... analysis is a technique used to determine the size of ... It is crucial to analyze the size of particles as ... size analysis is performed to determine the behavior and nature ...
(Date:7/25/2014)... 2014 "Ischemic Stroke and Cerebral ... data on the Ischemic Stroke and Cerebral Stroke ... and data relating to the clinical trials on ... global Ischemic Stroke Research Report 2014 at: ... the trial numbers and their recruitment status as ...
Breaking Biology Technology:Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Global Particle Size Analysis Market 2014-2018 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3
... to be Held Wednesday, May 7, 2008 at 10:00 ... Emisphere,Technologies, Inc. (Nasdaq: EMIS ) will host a ... ended March 31, 2008 on,Wednesday, May 7, 2008 at ... conference call can be accessed through the,company,s website at: ...
... scientists first learned to make nanowires, the nano-sized wires ... taken many forms, including nanobelts, nanocoils and nanoflowers. , ... and graduate student Matthew Bierman accidentally made some pine ... and branches that tapered in length as they spiraled ...
... HER3 Assays to Provide Unique Insights and ... Cancer Therapies, SOUTH SAN FRANCISCO, May 1 ... the company,s HER1,and HER3 Quantitative Protein Assays are now ... the HER1 and,HER3 assays provide unique, quantitative measurements of ...
Cached Biology Technology:Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results 2Spiraling nanotrees offer new twist on growth of nanowires 2Spiraling nanotrees offer new twist on growth of nanowires 3HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 2HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 3HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 4HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5
(Date:7/28/2014)... the Earth that are high priorities for conservation in ... vulnerable, as it has the lowest fraction of its ... in ,refugia, areas of biological diversity that support ... during times of great environmental change. The refugia that ... Scotland. , The biggest refugia are in the ...
(Date:7/28/2014)... CITY (July 28, 2014)The Brain & Behavior Research ... Klerman and Freedman Prizes, recognizing exceptional clinical and ... supported by NARSAD Young Investigator Grants. The grants ... in neurobiological and psychosocial research for the prevention, ... that affect one in four people. , Six ...
(Date:7/28/2014)... suffer from fertility problems, many of these due to ... might expect such genes, which reduce an individual,s ability ... the Weizmann Institute of Science that recently appeared in ... riddle. Not only can it explain the high rates ... in understanding the causes of genetic diseases and their ...
Breaking Biology News(10 mins):Study finds Europe's habitat and wildlife is vulnerable to climate change 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Mutations from Venus, mutations from Mars 2
... S-equol, a novel soy germ-based compound, is very likely ... dietary supplement SE5-OH, which is under development for reduction ... studies using an animal model presented at the Experimental ... advanced studies in menopausal women, and peer-reviewed reports have ...
... MIAMI - As Florida Governor Charlie Crist declared a ... scientists at the Center for Southeastern Tropical Advanced Remote ... actively collaborate with several international satellite data providers to ... The Deepwater Horizon oil platform caught fire after an ...
... first personalized treatment for lung cancer heralds the arrival ... will demand significant changes to the way cancer specialists ... today at the 2nd European Lung Cancer Conference in ... University of Vienna said that personalized therapy, in which ...
Cached Biology News:Natural S-Equol suggested as critical component in SE5-OH for reducing menopausal hot flushes 2Natural S-Equol suggested as critical component in SE5-OH for reducing menopausal hot flushes 3Natural S-Equol suggested as critical component in SE5-OH for reducing menopausal hot flushes 4Natural S-Equol suggested as critical component in SE5-OH for reducing menopausal hot flushes 5Making personalized lung cancer therapy a reality in Europe 2
...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
... Desselberger (1995) • This book is ... classical and molecular techniques currently used ... and analysis of virus-specific antibodies and ... presented covering immunoassays, blotting and hybridization ...
...
Biology Products: